• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail

Search results from the "OB_Rx" table for query on "075635."

Active Ingredient: ETOPOSIDE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: ETOPOSIDE
Applicant: MYLAN
Strength: 50MG
Application Number: A075635
Product Number: 001
Approval Date: Sep 19, 2001
Reference Listed Drug Yes
TE Code:
Patent and Exclusivity Info for this product: View

Return to Electronic Orange Book Home Page

FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through February 2015
Patent and Generic Drug Product Data Last Updated March 27, 2015